相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome
Ibraahim Badaat et al.
JOURNAL OF CLINICAL PATHOLOGY (2020)
Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective
Anneke D. van Dijk et al.
EXPERT REVIEW OF PROTEOMICS (2020)
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Friederike Hoffmann et al.
CLINICAL EPIGENETICS (2020)
DNA methylation markers in the diagnosis and prognosis of common leukemias
Hua Jiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes
Guoqiang Yi et al.
CELL REPORTS (2019)
A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
C. W. Hu et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Acceleration of AML Progression By Cigarette Smoke Exposure or Condensate Exposure and Associated DNA Methylation Alterations
Mary Figueroa et al.
BLOOD (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
Musa Yilmaz et al.
BLOOD CANCER JOURNAL (2019)
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Chao He et al.
CLINICAL EPIGENETICS (2019)
Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia
Steven M. Johnson et al.
HEMASPHERE (2019)
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah M. Katz et al.
ACTA NEUROPATHOLOGICA (2018)
KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia
Liberalis Debraj Boila et al.
EXPERIMENTAL HEMATOLOGY (2018)
Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
Yunan Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
Koichi Takahashi et al.
NATURE COMMUNICATIONS (2018)
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
Hsin-An Hou et al.
BLOOD CANCER JOURNAL (2018)
Association between H3K4 methylation and cancer prognosis: A meta-analysis
Simin Li et al.
THORACIC CANCER (2018)
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Haley E. Ramsey et al.
CANCER DISCOVERY (2018)
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
Pathways and mechanisms of venetoclax resistance
Prithviraj Bose et al.
LEUKEMIA & LYMPHOMA (2017)
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
Pooja Panwalkar et al.
ACTA NEUROPATHOLOGICA (2017)
Philadelphia Chromosome-like Acute Lymphoblastic Leukemia
Ching-Hon Pui et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V. I. Gaidzik et al.
LEUKEMIA (2016)
Adult Acute Lymphoblastic Leukemia
Shilpa Paul et al.
MAYO CLINIC PROCEEDINGS (2016)
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival
Arjen H. G. Cleven et al.
MODERN PATHOLOGY (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML
Courtney D. DiNardo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
Veronica Leoni et al.
HAEMATOLOGICA (2015)
Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
Veronica Leoni et al.
HAEMATOLOGICA (2015)
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
Shang-Ju Wu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations
Daichi Inoue et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics
O. Abdel-Wahab et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
Shang-Ju Wu et al.
BLOOD (2012)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts et al.
CANCER CELL (2012)
Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value
Marta Pratcorona et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient
Noriyoshi Iriyama et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype
Vera Grossmann et al.
BLOOD (2011)
Targeting PKC-Mediated Signal Transduction Pathways Using Enzastaurin to Promote Apoptosis in Acute Myeloid Leukemia-Derived Cell Lines and Blast Cells
Peter P. Ruvolo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
David B. Seligson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Functional proteomic profiling of AML predicts response and survival
Steven M. Kornblau et al.
BLOOD (2009)
Genome-wide Analysis of Histone Methylation Reveals Chromatin State-Based Regulation of Gene Transcription and Function of Memory CD8+ T Cells
Yasuto Araki et al.
IMMUNITY (2009)
New Genetic Abnormalities and Treatment Response in Acute Lymphoblastic Leukemia
Jules P. P. Meijerink et al.
SEMINARS IN HEMATOLOGY (2009)
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
Yongkun Wei et al.
MOLECULAR CARCINOGENESIS (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer
Yeshayahu Schlesinger et al.
NATURE GENETICS (2007)
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia
Steven M. Kornblau et al.
BLOOD (2006)
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Carlos Perez-Plasencia et al.
MOLECULAR CANCER (2006)
分享论文
